secwatch.observer — SEC 8-K summary
======================================

Issuer:     ICU MEDICAL INC/DE (ICUI)
CIK:        0000883984
Form:       8-K
Filed at:   2025-08-07T23:59:59+00:00
Accession:  0000883984-25-000029
Event type: earnings
Sentiment:  neutral
Materiality: 0.80
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

ICU Medical Q2 revenue down 8% to $549M, but GAAP net income of $35.3M vs year-ago loss
--------------------------------------------------------------------------------

- Revenue $548.9M vs $596.5M YoY; GAAP gross margin improved to 38% from 35%.
- GAAP net income $35.3M ($1.43 diluted EPS) vs net loss of $(21.4M) ($(0.88) EPS) in Q2 2024.
- Adjusted diluted EPS $2.10 vs $1.56 YoY; Adjusted EBITDA $100.3M vs $91.3M.
- Fiscal 2025 guidance updated in the press release; specifics not provided in excerpt.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/883984/000088398425000029/0000883984-25-000029-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/883984/000088398425000029/icui-20250807.htm
  HTML page:      https://secwatch.observer/filing/0000883984-25-000029

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer